Zenibell Snail Intensive Toner

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Zenibell Snail Intensive Toner
Generic name: GLYCERIN
Manufacturer: MISOCOS
Product type: HUMAN OTC DRUG
SPL set ID: 97c1b556-824d-bef7-e053-2a95a90ae1f2
SPL ID: 1c791086-2d31-9cbf-e063-6394a90a2601
Version: 2
Effective date: 2024-07-05
Source export date: 2026-10-30
Source partition: 1
Source file: https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/772d0e4623a189b47f3ab71d7d51f9b3c89c5526f4cf3d218e1c921bb964b80c/drug-label-0001-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 18:28:34

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 9 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Zenibell Snail Intensive Toner	openfda.brand_name
generic name		GLYCERIN	openfda.generic_name
manufacturer name		MISOCOS	openfda.manufacturer_name
ndc	package	73466-0003-1	openfda.package_ndc
ndc	product	73466-0003	openfda.product_ndc
ndc11	package	73466000301	derived:openfda.package_ndc
spl id		1c791086-2d31-9cbf-e063-6394a90a2601	id
spl set id		97c1b556-824d-bef7-e053-2a95a90ae1f2	set_id
unii		PDC6A3C0OX	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

■ if following abnormal symptoms occurs after use , stop use and consult with a skin specialist red specks, swelling, itching ■ don’t use on the part where there is injury, eczema, or dermatitis Keep out of reach of children ■ if swallowed, get medical help or contact a person control center immediately

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.